Cargando…

The Th17 Pathway in Vascular Inflammation: Culprit or Consort?

The involvement of IL-17A in autoimmune and inflammatory diseases has prompted the development of therapeutic strategies to block the Th17 pathway. Promising results came from their use in psoriasis and in ankylosing spondylitis. IL-17A acts on various cell types and has both local and systemic effe...

Descripción completa

Detalles Bibliográficos
Autores principales: Robert, Marie, Miossec, Pierre, Hot, Arnaud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035791/
https://www.ncbi.nlm.nih.gov/pubmed/35479069
http://dx.doi.org/10.3389/fimmu.2022.888763